Related Experiment Video

Updated: Jul 6, 2026

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

Salivary endothelin concentrations in the assessment of chronic heart failure

R Denver, A Tzanidis, P Martin

    Lancet (London, England)
    |June 7, 2000
    PubMed

    Insights

    Salivary endothelin levels are elevated in chronic heart failure patients, correlating with disease severity. Saliva endothelin may help identify early-stage heart failure symptoms.

    Area of Science:

    • Cardiovascular Medicine
    • Biomarker Discovery
    • Clinical Diagnostics

    Background:

    • Chronic heart failure (CHF) poses a significant global health burden.
    • Current diagnostic methods for CHF severity can be invasive or costly.
    • Identifying non-invasive biomarkers for CHF is crucial for patient management.

    Discussion:

    • Elevated salivary endothelin concentrations were observed in patients with chronic heart failure.
    • Salivary endothelin levels demonstrated a positive correlation with New York Heart Association (NYHA) Functional Classes, indicating disease progression.
    • These findings suggest salivary endothelin as a potential indicator of CHF severity.

    Key Insights:

    • Saliva endothelin levels are significantly higher in CHF patients compared to healthy controls.
    • Salivary endothelin concentrations appear capable of distinguishing between healthy individuals and those with mild CHF symptoms.
    • This research highlights the potential of saliva as a diagnostic fluid for cardiovascular conditions.

    Outlook:

    • Further validation studies are needed to confirm salivary endothelin as a reliable biomarker for CHF.
    • Investigating the therapeutic implications of targeting endothelin pathways in CHF.
    • Exploring the utility of salivary endothelin in monitoring treatment response and disease prognosis.

    More Related Videos

    Using Chicken Embryo as a Powerful Tool in Assessment of Developmental Cardiotoxicities11:00

    Using Chicken Embryo as a Powerful Tool in Assessment of Developmental Cardiotoxicities

    Published on: March 21, 2021

    LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium06:16

    LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium

    Published on: July 28, 2023

    Related Concept Videos

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

    Blood Studies for Cardiovascular System I: Cardiac Biomarkers

    Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
    The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
    Troponins
    Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...